3 x 200 mg/d bezafibrate and 3 x 500 mg/d clofibrate were administered for periods of 8 weeks each to 22 patients with primary hyperlipoproteinaemia ( 9 type iib , 13 type iv ) .
C0009002
clofibrate
C0020476
hyperlipoproteinaemia